재생불량성 빈혈 시장 기회 및 전략(-2035년)

Aplastic anemia is a rare and serious blood disorder in which the bone marrow fails to produce sufficient new blood cells, including red blood cells, white blood cells, and platelets. This condition results from damage to or destruction of hematopoietic stem cells in the bone marrow or by autoimmune processes, certain medications, radiation, infections, or genetic factors. The treatment of aplastic anemia is to restore normal blood cell production, manage symptoms, and prevent complications such as infections and bleeding.

The aplastic anemia market consists of sales by entities (organizations, sole traders and partnerships) of aplastic anemia services such as research, development, manufacturing and provision of therapies and medical services used to diagnose, manage and treat aplastic anemia. The market includes a range of pharmaceutical drugs, biologic therapies, blood products and stem cell transplantation services that aim to restore bone marrow function or manage the complications associated with the disorder.

The global aplastic anemia market was valued at $5,203.2 million in 2020 which grew till 2025 at a compound annual growth rate (CAGR) of more than 5.00%.

Rising Demand For Personalized Medicine

During the historic period, the aplastic anemia market was significantly driven by the rising demand for personalized medicine. As healthcare systems increasingly focused on tailoring treatments to individual patient characteristics, genomic analysis and precision diagnostics gained greater importance in the management of complex and rare hematological disorders. For instance, in February 2024, the U.S. Food and Drug Administration (FDA), a federal agency responsible for regulating drugs and medical devices, expanded the indications for many existing personalized therapies; approved six new gene and cell-based therapies; began reclassifying many class III (high-risk devices) into Class II (moderate-risk devices) in advance of pending regulatory reform of laboratory developed tests (LDTs); and approved many new diagnostic indications that will allow for targeted treatment decisions for various health conditions. Therefore, the aplastic anemia market was significantly driven by the rising demand for personalized medicine during the historic period.

Biotechnology, Genomics And Precision Medicine

Major companies in the aplastic anemia market are increasingly prioritizing biotechnology, genomics, and precision medicine to enable the development of advanced cell-based therapies and targeted treatments for rare hematological disorders. These initiatives use stem-cell engineering, genomic insights, and regenerative medicine approaches to restore healthy bone marrow function and improve long-term patient outcomes. For example, in December 2025, Gamida Cell Inc., an Israel-based biotechnology company focused on cell therapy innovation, announced that the U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv) as the first hematopoietic stem cell transplant therapy indicated for the treatment of severe aplastic anemia, using nicotinamide-modified cord blood stem cells to accelerate neutrophil recovery and restore blood and immune system function in patients lacking compatible donors.

The global aplastic anemia market is fragmented, with a large number of small players operating in the market. The top 10 competitors in the market made up 13.62% of the total market in 2024.

Aplastic Anemia Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global aplastic anemia market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for aplastic anemia? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The aplastic anemia market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider aplastic anemia; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segments, key products, supply chain and market attractiveness scoring and analysis.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future technologies and developments in the market.
• Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
• Global Market Size And Growth Global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by technology, by solution, by modality, by application and by end user in the market. historic (2020-2025) and forecast (2025-2030) and (2030-2035) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
• Recent Developments Information on recent developments in the market covered in the report.
• Market Opportunities And Strategies Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for aplastic anemia providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Disease Type: Acquired Aplastic Anemia; Inherited Bone Marrow Failure Syndromes
• 2) By Treatment Type: Bone Marrow Transfusion Or Stem Cell Therapy; Blood Transfusion; Drug Therapy
• 3) By Route Of Administration: Oral; Parentals; Other Routes Of Administration
• 4) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
• Companies Mentioned: Novartis AG; GlaxoSmithKline plc; Kyowa Kirin Co. Ltd.; Teva Pharmaceutical Industries Ltd.; Dr. Reddy's Laboratories Ltd.
• Countries: China; India; Japan; Australia; Indonesia; South Korea; USA; Canada; Brazil; UK; Germany; France; Italy; Spain; Russia; Taiwan
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; aplastic anemia indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Dashboard

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Aplastic Anemia Market Definition And Segmentations
• 6.4 Market Segmentation By Disease Type (Acquired Aplastic Anemia And Inherited Bone Marrow Failure Syndromes)
• 6.5 Market Segmentation By Treatment Type (Bone Marrow Transfusion Or Stem Cell Therapy, Blood Transfusion And Drug Therapy)
• 6.6 Market Segmentation By Route Of Administration (Oral, Parentals And Other Routes Of Administration)
• 6.7 Market Segmentation By End User (Hospitals, Homecare, Specialty Clinics And Other End Users)

7 Aplastic Anemia Market, Supply Chain Analysis

• 7.1 Aplastic Anemia Market, Overview Of Key Products/Services
• 7.2 Global Aplastic Anemia Market Attractiveness Scoring And Analysis
  • 7.2.1 Overview Of Market Attractiveness Framework
  • 7.2.2 Quantitative Scoring Methodology
  • 7.2.3 Market Attractiveness Scoring And Interpretation
  • 7.2.4 Factor-Wise Evaluation
  • 7.2.5 Strategic Implications And Recommendations

8 Major Market Trends

• 8.1 Key Technologies & Future Trends
  • 8.1.1 Biotechnology, Genomics And Precision Medicine
  • 8.1.2 Industry 4.0 And Intelligent Manufacturing
  • 8.1.3 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 8.1.4 Artificial Intelligence And Autonomous Intelligence
  • 8.1.5 Digitalization, Cloud, Big Data And Cybersecurity
• 8.2 Major Trends
  • 8.2.1 Expansion Of Strategic Manufacturing Partnerships For Cell Therapies
  • 8.2.2 Development Of Regulatory T-Cell Therapies For Bone Marrow Failure Disorders

9 Global Aplastic Anemia Growth Analysis And Strategic Analysis Framework

• 9.1 Global Aplastic Anemia PESTEL Analysis
  • 9.1.1 Political
  • 9.1.2 Economic
  • 9.1.3 Social
  • 9.1.4 Technological
  • 9.1.5 Environmental
  • 9.1.6 Legal
• 9.2 Analysis Of End User (B2B) Market
  • 9.2.1 Hospitals
  • 9.2.2 Homecare
  • 9.2.3 Other End Users
• 9.3 Global Aplastic Anemia Market Size And Growth Analysis
• 9.4 Historic Market Growth, 2020 - 2025, Value ($ Million)
  • 9.4.1 Market Drivers 2020 - 2025
  • 9.4.2 Market Restraints 2020 - 2025
• 9.5 Forecast Market Growth, 2025 - 2030, 2035F Value ($ Million)
• 9.6 Forecast Growth Contributors/Factors
  • 9.6.1 Quantitative Growth Contributors
  • 9.6.2 Drivers
  • 9.6.3 Restraints

10 Global Aplastic Anemia Total Addressable Market (TAM) Analysis

• 10.1 Definition And Scope of Total Addressable Market (TAM)
• 10.2 Methodology And Assumptions
  • 10.2.1 Total Addressable Market for the Aplastic Anemia Market - Business to Customer (B2C)
  • 10.2.2 TAM Comparison Analysis

11 Global Aplastic Anemia Market Segmentation

• 11.1 Global Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.2 Global Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.3 Global Aplastic Anemia Market, Sub Segmentation Of Drug Therapy, By Distribution Channel, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.4 Global Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.5 Global Aplastic Anemia Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.6 Global Aplastic Anemia Market, Sub Segmentation Of Acquired Aplastic Anemia, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.7 Global Aplastic Anemia Market, Sub-Segmentation Of Inherited Bone Marrow Failure Syndromes, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

12 Aplastic Anemia Market, Regional and Country Analysis

• 12.1 Global Aplastic Anemia Market, By Region, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.2 Global Aplastic Anemia Market, By Country, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

13 Asia-Pacific Market

• 13.1 Asia-Pacific Market Summary
• 13.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 13.3 Asia-Pacific Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.4 Asia-Pacific Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.5 Asia-Pacific Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.6 China Market
  • 13.6.1 China Market Summary
  • 13.6.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
  • 13.6.3 China Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.6.4 China Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.6.5 China Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.7 India Market
  • 13.7.1 India Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.7.2 India Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.7.3 India Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.8 Japan Market
  • 13.8.1 Japan Market Summary
  • 13.8.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 13.8.3 Japan Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.8.4 Japan Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.8.5 Japan Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.9 Australia Market
  • 13.9.1 Australia Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.9.2 Australia Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.9.3 Australia Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.10 South Korea Market
  • 13.10.1 South Korea Market Summary
  • 13.10.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 13.10.3 South Korea Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.10.4 South Korea Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.10.5 South Korea Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.11 Taiwan Market
  • 13.11.1 Taiwan Market Summary
  • 13.11.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
  • 13.11.3 Taiwan Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.11.4 Taiwan Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 13.11.5 Taiwan Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

14 South East Asia Market

• 14.1 South East Asia Market Summary
• 14.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 14.3 South East Asia Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.4 South East Asia Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.5 South East Asia Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.6 Indonesia Market
  • 14.6.1 Indonesia Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 14.6.2 Indonesia Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 14.6.3 Indonesia Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

15 Western Europe Market

• 15.1 Western Europe Market Summary
• 15.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 15.3 Western Europe Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.4 Western Europe Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.5 Western Europe Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.6 UK Market
  • 15.6.1 UK Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.6.2 UK Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.6.3 UK Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.7 Germany Market
  • 15.7.1 Germany Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.7.2 Germany Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.7.3 Germany Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.8 France Market
  • 15.8.1 France Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.8.2 France Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.8.3 France Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.9 Italy Market
  • 15.9.1 Italy Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.9.2 Italy Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.9.3 Italy Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.10 Spain Market
  • 15.10.1 Spain Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.10.2 Spain Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 15.10.3 Spain Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

16 Eastern Europe Market

• 16.1 Eastern Europe Market Summary
• 16.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
• 16.3 Eastern Europe Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.4 Eastern Europe Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.5 Eastern Europe Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.6 Russia Market
  • 16.6.1 Russia Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.6.2 Russia Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 16.6.3 Russia Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

17 North America Market

• 17.1 North America Market Summary
• 17.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 17.3 North America Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.4 North America Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.5 North America Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.6 USA Market
  • 17.6.1 USA Market Summary
  • 17.6.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 17.6.3 USA Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.6.4 USA Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.6.5 USA Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.7 Canada Market
  • 17.7.1 Canada Market Summary
  • 17.7.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
  • 17.7.3 Canada Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.7.4 Canada Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 17.7.5 Canada Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

18 South America Market

• 18.1 South America Market Summary
• 18.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
• 18.3 South America Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.4 South America Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.5 South America Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.6 Brazil Market
  • 18.6.1 Brazil Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.6.2 Brazil Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
  • 18.6.3 Brazil Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

19 Middle East Market

• 19.1 Middle East Market Summary
• 19.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
• 19.3 Middle East Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.4 Middle East Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.5 Middle East Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

20 Africa Market

• 20.1 Africa Market Summary
• 20.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure And Major Companies)
• 20.3 Africa Aplastic Anemia Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.4 Africa Aplastic Anemia Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.5 Africa Aplastic Anemia Market, Segmentation By Route Of Administration, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

21 Competitive Landscape And Company Profiles

• 21.1 Aplastic Anemia Market Competitive Landscape And & Market Share 2024
  • 21.1.1 Top 10 Companies (Ranked by revenue/share)
• 21.2 Company Profiles
• 21.3 Novartis AG (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 21.4 GlaxoSmithKline plc (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 21.5 Kyowa Kirin Co. Ltd (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 21.6 Teva Pharmaceutical Industries Ltd (TAPI) (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 21.7 Dr. Reddy's Laboratories Ltd (Company Overview, Products and Services, Business Strategy, Financial Overview)

22 Other Major And Innovative Companies

• 22.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Company Overview, Products and Services)
• 22.2 Sanofi SA (Company Overview, Products and Services)
• 22.3 Amgen Inc. (Company Overview, Products and Services)
• 22.4 Mayo Clinic (Company Overview, Products and Services)
• 22.5 Cleveland Clinic (Company Overview, Products and Services)
• 22.6 City of Hope National Medical Center (Company Overview, Products and Services)
• 22.7 Gamida Cell Ltd. (Ayrmid Pharma Ltd.) (Company Overview, Products and Services)
• 22.8 Amyndas Pharmaceuticals S.A. (Company Overview, Products and Services)
• 22.9 BioLineRx Ltd. (Company Overview, Products and Services)
• 22.10 Cellenkos Inc. (Company Overview, Products and Services)
• 22.11 Regeneron Pharmaceuticals (Company Overview, Products and Services)
• 22.12 Regen BioPharma Inc. (Company Overview, Products and Services)
• 22.13 Hemogenyx Pharmaceuticals Plc (Company Overview, Products and Services)
• 22.14 Qilu Pharmaceutical Co., Ltd. (Company Overview, Products and Services)
• 22.15 Pfizer Inc. (Company Overview, Products and Services)

23 Competitive Benchmarking

24 Competitive Dashboard

25 Aplastic Anemia Market - Company Scoring Matrix

• 25.1 Innovation & Brand Leaders
• 25.2 Emerging Innovators
• 25.3 Brand-Driven Traditionalists
• 25.4 Niche or Local Followers

26 Upcoming Startups In the Market

27 Recent Developments

• 27.1 Expansion Of Generic Drug Availability For Aplastic Anemia Treatment

28 Opportunities And Strategies

• 28.1 Global Aplastic Anemia Market In 2030 - Countries Offering Most New Opportunities
• 28.2 Global Aplastic Anemia Market In 2030 - Segments Offering Most New Opportunities
• 28.3 Global Aplastic Anemia Market In 2030 - Growth Strategies
  • 28.3.1 Market Trend Based Strategies
  • 28.3.2 Competitor Strategies

29 Aplastic Anemia Market, Conclusions And Recommendations

• 29.1 Conclusions
• 29.2 Recommendations
  • 29.2.1 Product
  • 29.2.2 Place
  • 29.2.3 Price
  • 29.2.4 Promotion
  • 29.2.5 People

30 Appendix

• 30.1 Geographies Covered
• 30.2 Market Data Sources
• 30.3 Research Methodology
• 30.4 Currencies
• 30.5 The Business Research Company
• 30.6 Copyright and Disclaimer